Search research articles
Contact Us
Filters
Showing results (281-290 of 286) with videos related to
Page
of 29
Sort By:
You have reached the last page of results.
This site can display upto 286 results.
Immunity
|
June 10, 1998
SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development
W Swat, K Fujikawa, S Ganiatsas, et al.
Australian Veterinary Journal
|
June 30, 2011
The first five days: field and laboratory investigations during the early stages of the equine influenza outbreak in Australia, 2007
P D Kirkland, R J Davis, D Wong, et al.
Australian Veterinary Journal
|
September 24, 1999
Epidemic of blindness in kangaroos--evidence of a viral aetiology
P T Hooper, R A Lunt, A R Gould, et al.
Lancet (London, England)
|
December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
A J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine
|
April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
P J Trainer, W M Drake, L Katznelson, et al.
Physical Review Letters
|
March 28, 2015
Joint analysis of BICEP2/keck array and Planck Data
P A R Ade, N Aghanim, Z Ahmed, et al.
Page
of 29
Search research articles
Search
Showing results (281-290 of 286) with videos related to
Sort By:
Page
of 29
You have reached the last page of results.
This site can display upto 286 results.
Immunity
|
June 10, 1998
SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development
W Swat, K Fujikawa, S Ganiatsas, et al.
Australian Veterinary Journal
|
June 30, 2011
The first five days: field and laboratory investigations during the early stages of the equine influenza outbreak in Australia, 2007
P D Kirkland, R J Davis, D Wong, et al.
Australian Veterinary Journal
|
September 24, 1999
Epidemic of blindness in kangaroos--evidence of a viral aetiology
P T Hooper, R A Lunt, A R Gould, et al.
Lancet (London, England)
|
December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
A J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine
|
April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
P J Trainer, W M Drake, L Katznelson, et al.
Physical Review Letters
|
March 28, 2015
Joint analysis of BICEP2/keck array and Planck Data
P A R Ade, N Aghanim, Z Ahmed, et al.
Page
of 29